A Recently Established Murine Model of Nasal Polyps Demonstrates Activation of B Cells, as Occurs in Human Nasal Polyps
- 1 August 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 55 (2) , 170-175
Abstract
Animal model systems are invaluable for examining human diseases. Our laboratory recently established a mouse model of nasal polyps (NPs) and investigated similarities and differences between this mouse model and human NPs. We especially focus on the hypothesis that B cell activation occurs during NP generation in the murine model. After induction of ovalbumin-induced allergic rhinosinusitis, 6% ovalbumin and Staphylococcus aureus enterotoxin B (10 ng) were instilled into the nasal cavity of mice three times per week for 8 weeks. The development of structures that somewhat resemble NPs (which we will refer to as NPs) was confirmed by hematoxylin and eosin staining. The mRNA and protein levels of various inflammatory cell markers and mediators were measured by real-time PCR in nasal tissue and by ELISA in nasal lavage fluid (NLF), respectively. Total Ig isotype levels in NLF were also quantitated using the Mouse Ig Isotyping Multiplex kit (EMD Millipore, Billerica, MA) on a Luminex 200 instrument (Life Technologies, Grand Island, NY). Similar to human NPs, there were significant increases in gene expression of inflammatory cell markers, such as CD19, CD138, CD11c, and mast cell protease-6 in nasal tissue samples of the NP group compared with those of the control group. In further investigations of B cell activation, mRNA expressions of B cell activating factor and a proliferation-inducing ligand were found to be significantly increased in mouse NP tissue. B cell–activating factor protein concentration and IgA and IgG1 levels in NLF were significantly higher in the NP group compared with the control group. In this study, the NP mouse model demonstrated enhanced B cell responses, which are reminiscent of B cell responses in human NPs.Keywords
This publication has 23 references indexed in Scilit:
- Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2011
- Effector and regulatory B cells: modulators of CD4+ T cell immunityNature Reviews Immunology, 2010
- Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polypsJournal of Allergy and Clinical Immunology, 2008
- Local immunoglobulin production in nasal polyposis is modulated by superantigensClinical & Experimental Allergy, 2007
- Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissueAllergy, 2004
- Regulation of Immunoglobulin Secretion by Plasma Cells Infiltrating Nasal PolypsThe Laryngoscope, 2000
- Nasal polyposis: Immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps)Journal of Allergy and Clinical Immunology, 1997
- Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivoEuropean Journal of Immunology, 1995
- Mucosal allergy in the absence of systemic allergy in nasal polyposis and rhinitis: A meta-analysisOtolaryngology–Head and Neck Surgery, 1994
- Measurement of specific IgE antibodies in nasal secretion—evidence for local productionClinical & Experimental Allergy, 1976